4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-22-035689
Options or other derivatives
- Director acquired 43,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Souza Marcio Director | 2022-06-07 | Grant or award · Director Stock Option (right to buy) | +43,000 | 43,000 | D | ||
Loading xslF345X03/doc4.xml…